MethylGene is the older company (1997 vs 2018).
Side-by-Side Comparison
| Metric | MethylGene | Ventyx Biosciences |
|---|---|---|
| Founded | ||
| Founded | 1997 older | 2018 |
| Headquarters | ||
| Headquarters | Not tracked yet | San Diego, United States |
| Employees | ||
| Employees | Not tracked yet | 242 |
| Industry | ||
| Industry | Biopharma, Biotechnology | Biopharma, Biotechnology |
| Funding Stage | ||
| Funding Stage | Series Unknown | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $71.83M | $441.60M |
| Funding Rounds | ||
| Funding Rounds | 4 | 4 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical Company, Clinical Stage, Cancer Therapeutics, Kinase Inhibitors, HDAC Inhibitors, Oncology, Pharmaceutical Research, Clinical Trials, Drug Development, Neurodegenerative Diseases, Publicly Traded, Oncology Treatments, MethylGene Inc., Taiho Pharmaceutical Co. Ltd. | Clinical Stage Programs, Inflammatory Diseases, Autoimmune Disorders, TYK2 Inhibitor, S1P1 Receptor Modulator, Ulcerative Colitis, NLRP3 Inflammasome, Phase 1 Clinical Trials, Phase 2 Clinical Trials, Drug Development, Fraud Alert, Cybercrime, FBI Warning, Pharmaceutical Industry |
| Website | ||
| Website | methylgene.com | ventyxbio.com |
About MethylGene
MethylGene is a clinical stage biopharmaceutical company dedicated to the development and commercialization of innovative therapeutics primarily targeting cancer. Founded in 1997, it trades on the public market under the symbol TSX:MYG. The company's product portfolio includes MGCD265, an oral, mult...
About Ventyx Biosciences
Ventyx Biosciences is a biotechnology company founded in 2018. It has a diverse portfolio of highly differentiated clinical and pre-clinical stage programs targeting high-value areas. The company's combined assets originate from three separate entities: Oppilan Pharma, focusing on S1P1R; Zomagen Bio...
We will tell you when either one moves
BounceWatch watches MethylGene and Ventyx Biosciences for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at MethylGene and Ventyx Biosciences — by email.
Frequently Asked Questions
Compare MethylGene with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at MethylGene on 19 Jun 2024, and Ventyx Biosciences on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.